SEC 13F Intelligence

Payden & Rygel / ELV

Payden & Rygel’s Elevance Health Inc Formerly Position

Does Payden & Rygel own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 40.9K shares worth $19M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$19M
Q1 2023
Shares
40.9K
% of Portfolio
+1.11%
Quarters Held
9
position exited

Position History ELV

Reported value by quarter
Q1 ’21: $23MQ1 ’21Q2 ’21: $25MQ3 ’21: $24MQ3 ’21Q4 ’21: $881,000Q1 ’22: $2MQ1 ’22Q2 ’22: $19MQ3 ’22: $30MQ3 ’22Q4 ’22: $35MQ1 ’23: $19MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202340.9K$19M+1.11%
Q4 202267.9K$35M+1.86%
Q3 202266.4K$30M+1.76%
Q2 202239.2K$19M+1.14%
Q1 20223.8K$2M+0.09%
Q4 20211.9K$881,000+0.04%
Q3 202165.1K$24M+1.26%
Q2 202165.3K$25M+1.19%
Q1 202165.2K$23M+1.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Payden & Rygel’s full portfolio or all institutional holders of ELV.